262 related articles for article (PubMed ID: 31187224)
1. Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.
Ahmed SA; El-Mahallawy HS; Karanis P
Parasitol Res; 2019 Jul; 118(7):2053-2063. PubMed ID: 31187224
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
3. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
[TBL] [Abstract][Full Text] [Related]
4. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
5. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy.
Blanco-García E; Guerrero-Callejas F; Blanco-Méndez J; Gómez-Couso H; Luzardo-Álvarez A
Eur J Pharm Sci; 2016 Sep; 92():74-85. PubMed ID: 27381880
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of amine-based disinfectant KENO™COX on the infectivity of Cryptosporidium parvum oocysts.
Naciri M; Mancassola R; Fort G; Danneels B; Verhaeghe J
Vet Parasitol; 2011 Jun; 179(1-3):43-9. PubMed ID: 21354705
[TBL] [Abstract][Full Text] [Related]
8. Silver Nanoparticles Decrease the Viability of Cryptosporidium parvum Oocysts.
Cameron P; Gaiser BK; Bhandari B; Bartley PM; Katzer F; Bridle H
Appl Environ Microbiol; 2016 Jan; 82(2):431-7. PubMed ID: 26497464
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
10. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Screening of Drugs Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR.
Zhang H; Zhu G
Methods Mol Biol; 2020; 2052():319-334. PubMed ID: 31452170
[TBL] [Abstract][Full Text] [Related]
12. Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture.
Woolsey ID; Valente AH; Williams AR; Thamsborg SM; Simonsen HT; Enemark HL
Sci Rep; 2019 Dec; 9(1):20414. PubMed ID: 31892721
[TBL] [Abstract][Full Text] [Related]
13. Feeding activated charcoal from bark containing wood vinegar liquid (nekka-rich) is effective as treatment for cryptosporidiosis in calves.
Watarai S; Tana ; Koiwa M
J Dairy Sci; 2008 Apr; 91(4):1458-63. PubMed ID: 18349239
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
[TBL] [Abstract][Full Text] [Related]
15. Antiprotozoal activity of silver nanoparticles against Cryptosporidium parvum oocysts: New insights on their feasibility as a water disinfectant.
Hassan D; Farghali M; Eldeek H; Gaber M; Elossily N; Ismail T
J Microbiol Methods; 2019 Oct; 165():105698. PubMed ID: 31446036
[TBL] [Abstract][Full Text] [Related]
16. Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin.
Meamar AR; Rezaian M; Rezaie S; Mohraz M; Kia EB; Houpt ER; Solaymani-Mohammadi S
Parasitol Res; 2006 May; 98(6):593-5. PubMed ID: 16416289
[TBL] [Abstract][Full Text] [Related]
17. Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection.
Joachim A; Eckert E; Petry F; Bialek R; Daugschies A
Vet Parasitol; 2003 Jan; 111(1):47-57. PubMed ID: 12523978
[TBL] [Abstract][Full Text] [Related]
18. Short communication: effect of pomegranate-residue supplement on Cryptosporidium parvum oocyst shedding in neonatal calves.
Weyl-Feinstein S; Markovics A; Eitam H; Orlov A; Yishay M; Agmon R; Miron J; Izhaki I; Shabtay A
J Dairy Sci; 2014 Sep; 97(9):5800-5. PubMed ID: 24952772
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.
Klein P; Cirioni O; Giacometti A; Scalise G
J Antimicrob Chemother; 2008 Nov; 62(5):1101-4. PubMed ID: 18653486
[TBL] [Abstract][Full Text] [Related]
20. High-Content Screening for Cryptosporidium Drug Discovery.
Love MS; McNamara CW
Methods Mol Biol; 2020; 2052():303-317. PubMed ID: 31452169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
